|

Pioglitazone Clinical Trials

10 actively recruiting trials across 3 locations

Also known as: Actos, Actos Tab., PIO, actos

Other4 trials

A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
Phase 2
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
Early 1
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Phase 3
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Phase 4

San Antonio, Texas4 trials

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

University Health System Texas Diabetic Institute

Phase 3
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Texas Diabetes Institute/UH

Phase 4
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio

N/A
Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System

Phase 4

Gainesville, Florida1 trial

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

University of Florida

Phase 2

Bethesda, Maryland1 trial

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.